查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1957639

2026年全球药品单剂量包装市场报告

Pharmaceutical Unit-Dose Packaging Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，单剂量药品包装市场发展迅速。预计该市场将从2025年的545亿美元成长到2026年的607.9亿美元，年复合成长率达11.6%。过去几年的成长主要归功于医院加强药物安全措施、对精准用药需求增加、注射和生物製药製剂的推广应用、门诊服务的成长以及药品包装材料的进步。

预计未来几年，单剂量药品包装市场将快速成长，到2030年将达到930.7亿美元，复合年增长率（CAGR）为11.2%。预测期内的成长预计将受到以下因素的推动：智慧包装技术的广泛应用、对以患者为中心的给药方式的日益重视、生物製药和特种药品的扩张、对合规包装需求的增加以及药品包装生产线自动化水平的提高。预测期内的关键趋势包括：安全单剂量包装的广泛应用、对泡壳和预填充式注射器形式的需求增加、追踪技术的广泛应用、高阻隔包装材料的普及以及对减少药物滥用的日益重视。

预计未来几年，免疫接种计划和疫苗宣传活动的扩大将推动单剂量药品包装市场的成长。免疫接种计划和疫苗宣传活动是旨在透过系统性地接种疫苗来保护民众免受感染疾病的公共卫生措施。这些计画和宣传活动的扩大是由于感染疾病率的上升，促使各国政府和卫生组织加强感染预防措施，并保护公众健康。单剂量药品包装透过确保剂量准确、最大限度地减少药物滥用、保持无菌以及便于大规模疫苗接种活动中的分发和接种，为免疫接种计划和疫苗接种宣传活动提供支持。例如，根据英国政府机构英国卫生安全局的数据，截至2023年6月，在2022-2023学年，共有3,502,566名从学前班到九年级的儿童和学生在学龄免疫接种计划中接种了疫苗。相较之下，2021-2022学年同年龄层的儿童人数为3,615,536人。因此，免疫接种计划和疫苗接种宣传活动的扩大正在推动单剂量药品包装市场的成长。

在药品单剂量包装市场中，主要企业正致力于开发先进的解决方案，例如无菌单剂量学名药，以提高给药的准确性并简化医院和药房的操作流程。无菌单剂量学名药是预先计量并独立包装的药物，可确保安全、准确地给药，避免微生物污染，是品牌无菌药物的一种经济有效的替代方案。例如，2023年8月，美国製药公司Ritedose Pharmaceuticals宣布推出色甘酸钠吸入溶液USP（20毫克/2毫升）。这种新型无菌单剂量学名药是一种吸入式抗发炎药，用于预防和控制气喘，每盒包含60支单剂量管瓶。这扩展了Ritedose的吸入溶液产品线，并确保为需要定期使用药物的客户提供稳定的供应。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球药品单剂量包装市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略适宜性评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 清单：主要原料、资源和供应商
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章：全球市场趋势与策略

  • 关键科技与未来趋势
    • 永续性、气候技术、循环经济
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料、网路安全
    • 物联网、智慧基础设施、互联生态系统
    • 人工智慧（AI）和自主人工智慧
  • 主要趋势
    • 单剂量安全包装的推广
    • 对泡壳包装和预填充式注射器形式的需求增加。
    • 追踪溯源技术整合的进展
    • 高阻隔包装材料的扩展
    • 人们越来越关注减少药物滥用问题

第五章 终端用户产业市场分析

  • 医院
  • 药局
  • 製药公司
  • 居家医疗服务提供者
  • 合约包装组织

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及 COVID-19 疫情对市场的影响。

第七章：全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球药品单剂量包装市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球药品单剂量包装市场规模、对比及成长率分析
  • 全球药品单剂量包装市场表现：规模与成长，2020-2025年
  • 全球药品单剂量包装市场预测：规模与成长，2025-2030年，2035年预测

第八章：全球市场总规模（TAM）

第九章 市场细分

  • 副产品
  • 泡壳包装、安瓿瓶、管瓶、预填充式注射器和药筒
  • 材料
  • 塑胶、玻璃、纸张和纸板、金属
  • 按最终用途
  • 眼科用药、注射、生物製药、创伤护理、呼吸系统治疗、口服药物
  • 依类型细分：泡壳包装
  • 推压式泡壳、剥离式泡壳、冷成型泡壳、热成型泡壳
  • 按类型细分：安瓿瓶
  • 开口安瓿、闭口安瓿、火焰密封安瓿、压力密封安瓿
  • 按类型细分：管瓶
  • 单剂量管瓶、多剂量管瓶、压盖颈管瓶、螺旋颈管瓶
  • 按类型细分：预填充式注射器和药筒
  • 一次性预填充式注射器、可重复使用预填充式注射器、玻璃药筒、塑胶药筒

第十章 区域与国别分析

  • 全球药品单剂量包装市场：依地区划分，历史资料及预测（2020-2025年、2025-2030年预测、2035年预测）
  • 全球药品单剂量包装市场：依国家划分，实际值及预测值，2020-2025年、2025-2030年预测值、2035年预测值

第十一章 亚太市场

第十二章：中国市场

第十三章：印度市场

第十四章：日本市场

第十五章：澳洲市场

第十六章：印尼市场

第十七章：韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第20章 西欧市场

第21章英国市场

第22章：德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章：东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第三十章：加拿大市场

第31章：南美市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第三十五章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 药品单剂量包装市场：竞争格局及市场占有率（2024年）
  • 药品单剂量包装市场：公司估值矩阵
  • 药品单剂量包装市场：公司概况
    • Pfizer Inc.
    • Johnson & Johnson Innovation LLC
    • Merck & Co. Inc.
    • AbbVie Inc.
    • Becton Dickinson and Company

第37章 其他大型企业和创新企业

  • Amcor Plc, Nipro Corporation, Aptar Group Inc., West Pharmaceutical Services Inc., Constantia Flexibles Group GmbH, Klockner Pentaplast, Stevanato Group SpA, SGD SA, SP Group, Jones Healthcare Group, Innovative Pharmacy Packaging Corporation Inc., Medical Packaging Inc. LLC, Adelphi Healthcare Packaging, Sonic Packaging Industries, Alfipa

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年药品单剂量包装市场：提供新机会的国家
  • 2030年药品单剂量包装市场：充满新机会的细分市场
  • 2030年药品单剂量包装市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第41章附录

简介目录
Product Code: PH6MPUDP01_G26Q1

Pharmaceutical unit-dose packaging involves packaging medication in individual, pre-measured containers. Its primary purpose is to provide accurate dosing, reduce medication errors, and improve patient safety. It also helps preserve drug stability, extend shelf life, and enables easy handling and administration in hospitals, pharmacies, and home care settings.

The primary product types in pharmaceutical unit-dose packaging include blisters, ampoules, vials, and prefilled syringes and cartridges. Blisters in pharmaceutical unit-dose packaging are sealed compartments made of plastic or aluminum that individually enclose a single tablet or capsule, providing product protection, precise dosing, and tamper evidence. They are manufactured from various materials such as plastics, glass, paper and paperboard, and metal, and are used for multiple applications, including ophthalmic, injectable, biologics, wound care, respiratory therapy, and oral.

Tariffs are impacting the pharmaceutical unit-dose packaging market by increasing costs of imported plastics, specialty glass, aluminum foils, and packaging machinery used across blisters, vials, ampoules, and prefilled syringes. North America and Europe are most affected due to reliance on imported raw materials and equipment, while Asia-Pacific faces pricing pressure on packaging exports. These tariffs are raising production costs and affecting packaging margins. However, they are also driving local material sourcing, regional packaging manufacturing expansion, and innovation in cost-efficient and sustainable unit-dose packaging solutions.

The pharmaceutical unit-dose packaging market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical unit-dose packaging market statistics, including pharmaceutical unit-dose packaging industry global market size, regional shares, competitors with a pharmaceutical unit-dose packaging market share, detailed pharmaceutical unit-dose packaging market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical unit-dose packaging industry. This pharmaceutical unit-dose packaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceutical unit-dose packaging market size has grown rapidly in recent years. It will grow from $54.5 billion in 2025 to $60.79 billion in 2026 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to increasing hospital medication safety initiatives, rising demand for precise drug dosing, expansion of injectable and biologic therapies, growth of outpatient care settings, advancements in pharmaceutical packaging materials.

The pharmaceutical unit-dose packaging market size is expected to see rapid growth in the next few years. It will grow to $93.07 billion in 2030 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to increasing adoption of smart packaging technologies, rising focus on patient-centric drug delivery, expansion of biologics and specialty drugs, growing demand for compliance-ready packaging, increasing automation in pharmaceutical packaging lines. Major trends in the forecast period include increasing adoption of unit-dose safety packaging, rising demand for blister and prefilled syringe formats, growing integration of track-and-trace technologies, expansion of high-barrier packaging materials, enhanced focus on medication error reduction.

The expansion of immunization programs and vaccination campaigns is anticipated to drive the growth of the pharmaceutical unit-dose packaging market in the coming years. Immunization programs and vaccination campaigns are organized public health efforts aimed at protecting populations from infectious diseases through the systematic administration of vaccines. The growth in these programs and campaigns is fueled by the increasing occurrence of infectious disease outbreaks, prompting governments and health organizations to enhance measures to prevent transmission and safeguard public health. Pharmaceutical unit-dose packaging supports immunization programs and vaccination campaigns by ensuring precise dosing, minimizing medication errors, maintaining sterility, and facilitating distribution and administration in large-scale vaccination initiatives. For example, in June 2023, according to the UK Health Security Agency, a UK government agency, the school-aged vaccination program recorded a total of 3,502,566 children (from Reception to Year 9) vaccinated in 2022-2023, compared to 3,615,536 children in the same age group during 2021-2022. Thus, the expansion of immunization programs and vaccination campaigns is driving the growth of the pharmaceutical unit-dose packaging market.

Major companies operating in the pharmaceutical unit-dose packaging market are concentrating on creating advanced solutions such as sterile unit-dose generic products to enhance dosing accuracy and optimize hospital and pharmacy workflows. Sterile unit-dose generic products consist of pre-measured, individually packaged medications designed to be free from microbial contamination, ensuring safe and precise dosing while providing a cost-effective alternative to branded sterile drugs. For example, in August 2023, Ritedose Pharmaceuticals, a US-based pharmaceutical company, introduced a cromolyn sodium inhalation solution, USP (20 mg/2 ml). This new sterile unit-dose generic product serves as an inhaled anti-inflammatory agent for the preventive management of asthma and is provided in cartons containing 60 single-dose vials. It broadens Ritedose's range of inhalation solutions and ensures a dependable supply for clients requiring this medication regularly.

In November 2024, Safecor Health, a US-based unit-dose repackaging company, acquired the US unit-dose packaging business from Viatris Inc. for an undisclosed sum. Through this acquisition, Safecor Health intends to broaden its generic unit-dose product portfolio, improve cost efficiency, and reinforce its supply chain partnerships to deliver more comprehensive solutions to healthcare providers and manufacturers. Viatris Inc. is a US-based pharmaceutical company that provides pharmaceutical unit-dose packaging.

Major companies operating in the pharmaceutical unit-dose packaging market are Pfizer Inc., Johnson & Johnson Innovation LLC, Merck & Co. Inc., AbbVie Inc., Becton Dickinson and Company, Amcor Plc, Nipro Corporation, Aptar Group Inc., West Pharmaceutical Services Inc., Constantia Flexibles Group GmbH, Klockner Pentaplast, Stevanato Group S.p.A., SGD SA, SP Group, Jones Healthcare Group, Innovative Pharmacy Packaging Corporation Inc., Medical Packaging Inc. LLC, Adelphi Healthcare Packaging, Sonic Packaging Industries, Alfipa, Unit Pack Company Inc.

North America was the largest region in the pharmaceutical unit-dose packaging market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical unit-dose packaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmaceutical unit-dose packaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical unit-dose packaging market consists of sales of products such as unit-dose pouches, sachets, strip packs, stick packs, prefilled droppers, nasal spray units, and ophthalmic single-dose containers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Unit-Dose Packaging Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pharmaceutical unit-dose packaging market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical unit-dose packaging ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmaceutical unit-dose packaging market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Blisters; Ampoules; Vials; Prefilled Syringes And Cartridges
  • 2) By Material: Plastics; Glass; Paper And Paperboard; Metal
  • 3) By End-Use: Ophthalmic; Injectable; Biologics; Wound Care; Respiratory Therapy; Orals
  • Subsegments:
  • 1) By Blisters: Push-Through Blisters; Peelable Blisters; Cold Formed Blisters; Thermoformed Blisters
  • 2) By Ampoules: Open Ampoules; Closed Ampoules; Flame-Sealed Ampoules; Pressure-Sealed Ampoules
  • 3) By Vials: Single-Dose Vials; Multi-Dose Vials; Crimp Neck Vials; Screw Neck Vials
  • 4) By Prefilled Syringes And Cartridges: Disposable Prefilled Syringes; Reusable Prefilled Syringes; Glass Cartridges; Plastic Cartridges
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson Innovation LLC; Merck & Co. Inc.; AbbVie Inc.; Becton Dickinson and Company; Amcor Plc; Nipro Corporation; Aptar Group Inc.; West Pharmaceutical Services Inc.; Constantia Flexibles Group GmbH; Klockner Pentaplast; Stevanato Group S.p.A.; SGD SA; SP Group; Jones Healthcare Group; Innovative Pharmacy Packaging Corporation Inc.; Medical Packaging Inc. LLC; Adelphi Healthcare Packaging; Sonic Packaging Industries; Alfipa; Unit Pack Company Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Pharmaceutical Unit-Dose Packaging Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Pharmaceutical Unit-Dose Packaging Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Pharmaceutical Unit-Dose Packaging Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Pharmaceutical Unit-Dose Packaging Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Sustainability, Climate Tech & Circular Economy
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Unit-Dose Safety Packaging
    • 4.2.2 Rising Demand For Blister And Prefilled Syringe Formats
    • 4.2.3 Growing Integration Of Track-And-Trace Technologies
    • 4.2.4 Expansion Of High-Barrier Packaging Materials
    • 4.2.5 Enhanced Focus On Medication Error Reduction

5. Pharmaceutical Unit-Dose Packaging Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Pharmacies
  • 5.3 Pharmaceutical Manufacturers
  • 5.4 Home Healthcare Providers
  • 5.5 Contract Packaging Organizations

6. Pharmaceutical Unit-Dose Packaging Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pharmaceutical Unit-Dose Packaging Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Pharmaceutical Unit-Dose Packaging PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Pharmaceutical Unit-Dose Packaging Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Pharmaceutical Unit-Dose Packaging Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Pharmaceutical Unit-Dose Packaging Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pharmaceutical Unit-Dose Packaging Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pharmaceutical Unit-Dose Packaging Market Segmentation

  • 9.1. Global Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blisters, Ampoules, Vials, Prefilled Syringes And Cartridges
  • 9.2. Global Pharmaceutical Unit-Dose Packaging Market, Segmentation By Material, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Plastics, Glass, Paper And Paperboard, Metal
  • 9.3. Global Pharmaceutical Unit-Dose Packaging Market, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Ophthalmic, Injectable, Biologics, Wound Care, Respiratory Therapy, Orals
  • 9.4. Global Pharmaceutical Unit-Dose Packaging Market, Sub-Segmentation Of Blisters, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Push-Through Blisters, Peelable Blisters, Cold Formed Blisters, Thermoformed Blisters
  • 9.5. Global Pharmaceutical Unit-Dose Packaging Market, Sub-Segmentation Of Ampoules, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Open Ampoules, Closed Ampoules, Flame-Sealed Ampoules, Pressure-Sealed Ampoules
  • 9.6. Global Pharmaceutical Unit-Dose Packaging Market, Sub-Segmentation Of Vials, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-Dose Vials, Multi-Dose Vials, Crimp Neck Vials, Screw Neck Vials
  • 9.7. Global Pharmaceutical Unit-Dose Packaging Market, Sub-Segmentation Of Prefilled Syringes And Cartridges, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Disposable Prefilled Syringes, Reusable Prefilled Syringes, Glass Cartridges, Plastic Cartridges

10. Pharmaceutical Unit-Dose Packaging Market Regional And Country Analysis

  • 10.1. Global Pharmaceutical Unit-Dose Packaging Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Pharmaceutical Unit-Dose Packaging Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pharmaceutical Unit-Dose Packaging Market

  • 11.1. Asia-Pacific Pharmaceutical Unit-Dose Packaging Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pharmaceutical Unit-Dose Packaging Market

  • 12.1. China Pharmaceutical Unit-Dose Packaging Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pharmaceutical Unit-Dose Packaging Market

  • 13.1. India Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pharmaceutical Unit-Dose Packaging Market

  • 14.1. Japan Pharmaceutical Unit-Dose Packaging Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pharmaceutical Unit-Dose Packaging Market

  • 15.1. Australia Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pharmaceutical Unit-Dose Packaging Market

  • 16.1. Indonesia Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pharmaceutical Unit-Dose Packaging Market

  • 17.1. South Korea Pharmaceutical Unit-Dose Packaging Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pharmaceutical Unit-Dose Packaging Market

  • 18.1. Taiwan Pharmaceutical Unit-Dose Packaging Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pharmaceutical Unit-Dose Packaging Market

  • 19.1. South East Asia Pharmaceutical Unit-Dose Packaging Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pharmaceutical Unit-Dose Packaging Market

  • 20.1. Western Europe Pharmaceutical Unit-Dose Packaging Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pharmaceutical Unit-Dose Packaging Market

  • 21.1. UK Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pharmaceutical Unit-Dose Packaging Market

  • 22.1. Germany Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pharmaceutical Unit-Dose Packaging Market

  • 23.1. France Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pharmaceutical Unit-Dose Packaging Market

  • 24.1. Italy Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pharmaceutical Unit-Dose Packaging Market

  • 25.1. Spain Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pharmaceutical Unit-Dose Packaging Market

  • 26.1. Eastern Europe Pharmaceutical Unit-Dose Packaging Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pharmaceutical Unit-Dose Packaging Market

  • 27.1. Russia Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pharmaceutical Unit-Dose Packaging Market

  • 28.1. North America Pharmaceutical Unit-Dose Packaging Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pharmaceutical Unit-Dose Packaging Market

  • 29.1. USA Pharmaceutical Unit-Dose Packaging Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pharmaceutical Unit-Dose Packaging Market

  • 30.1. Canada Pharmaceutical Unit-Dose Packaging Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pharmaceutical Unit-Dose Packaging Market

  • 31.1. South America Pharmaceutical Unit-Dose Packaging Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pharmaceutical Unit-Dose Packaging Market

  • 32.1. Brazil Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pharmaceutical Unit-Dose Packaging Market

  • 33.1. Middle East Pharmaceutical Unit-Dose Packaging Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pharmaceutical Unit-Dose Packaging Market

  • 34.1. Africa Pharmaceutical Unit-Dose Packaging Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Pharmaceutical Unit-Dose Packaging Market, Segmentation By Product, Segmentation By Material, Segmentation By End-Use, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pharmaceutical Unit-Dose Packaging Market Regulatory and Investment Landscape

36. Pharmaceutical Unit-Dose Packaging Market Competitive Landscape And Company Profiles

  • 36.1. Pharmaceutical Unit-Dose Packaging Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Pharmaceutical Unit-Dose Packaging Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Pharmaceutical Unit-Dose Packaging Market Company Profiles
    • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Johnson & Johnson Innovation LLC Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

37. Pharmaceutical Unit-Dose Packaging Market Other Major And Innovative Companies

  • Amcor Plc, Nipro Corporation, Aptar Group Inc., West Pharmaceutical Services Inc., Constantia Flexibles Group GmbH, Klockner Pentaplast, Stevanato Group S.p.A., SGD SA, SP Group, Jones Healthcare Group, Innovative Pharmacy Packaging Corporation Inc., Medical Packaging Inc. LLC, Adelphi Healthcare Packaging, Sonic Packaging Industries, Alfipa

38. Global Pharmaceutical Unit-Dose Packaging Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pharmaceutical Unit-Dose Packaging Market

40. Pharmaceutical Unit-Dose Packaging Market High Potential Countries, Segments and Strategies

  • 40.1 Pharmaceutical Unit-Dose Packaging Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Pharmaceutical Unit-Dose Packaging Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Pharmaceutical Unit-Dose Packaging Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer